Multinomial phase II trial designs

J Clin Oncol. 2002 Jan 15;20(2):599.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Clinical Trials, Phase II as Topic*
  • Decision Making
  • Disease Progression
  • Endpoint Determination*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Reproducibility of Results
  • Research Design
  • Statistics as Topic

Substances

  • Antineoplastic Agents